The transaction, which calls for a cash-out of around 55 million Australian dollars (around 34 million euro), perfectly fits Amplifon’s strategy aimed at further strengthening the Company’s position in the core Australian market, complementing National Hearing Care retail business with Attune’s integrated medical model.